Simple Summary This narrative literature review delves into the role of EPH/ephrin signaling
in liver cancer and its implications for tumor progression and potential therapeutic strategies …

The escalating global prevalence of obesity and its intricate association with the
development of hepatocellular carcinoma (HCC) pose a substantial challenge to public …

Hepatocellular carcinoma (HCC) is one of the leading contributors to cancer-related
mortality worldwide. Nop2/Sun domain family member 5 (NSUN5), a conserved RNA 5 …

In light of a global rise in the number of patients with type 2 diabetes mellitus (T2DM) and
obesity, non-alcoholic fatty liver disease (NAFLD), now known as metabolic dysfunction …

Nonalcoholic fatty liver disease (NAFLD) has become an increasingly common disease in
Western countries and has become the major cause of liver cirrhosis or hepatocellular …

Simple Summary The prevalence of nonalcoholic fatty liver disease (NAFLD)-associated
hepatocellular carcinoma (HCC) is rapidly increasing, following the growing prevalence of …

Liver diseases have consistently posed substantial challenges to global health. It is crucial
to find innovative methods to effectively prevent and treat these diseases. In recent times …

Hepatocellular carcinoma (HCC) is the most common type of liver cancer with a high death
rate in the world. The molecular mechanisms related to the pathogenesis of HCC have not …

Nonalcoholic fatty liver disease (NAFLD) is one of the leading causes of chronic liver
disease worldwide. Epidemiological studies have reported that exposure of the population …

Hepatocellular carcinoma (HCC) shows the highest morbidity among liver cancers and
accounts for a major factor inducing cancer-associated mortality globally. It is characterized …